495018
1-(tert-Butoxycarbonyl)-3-piperidinecarboxylic acid
98%
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
98%
reaction suitability
reaction type: solution phase peptide synthesis
mp
159-162 °C (lit.)
application(s)
peptide synthesis
SMILES string
CC(C)(C)OC(=O)N1CCCC(C1)C(O)=O
InChI
1S/C11H19NO4/c1-11(2,3)16-10(15)12-6-4-5-8(7-12)9(13)14/h8H,4-7H2,1-3H3,(H,13,14)
InChI key
NXILIHONWRXHFA-UHFFFAOYSA-N
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
PloS one, 10(8), e0136242-e0136242 (2015-08-22)
CCG-1423 suppresses several pathological processes including cancer cell migration, tissue fibrosis, and the development of atherosclerotic lesions. These suppressions are caused by inhibition of myocardin-related transcription factor A (MRTF-A), which is a critical factor for epithelial-mesenchymal transition (EMT). CCG-1423 can
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service